跳至主要内容
临床试验/SLCTR/2017/028
SLCTR/2017/028招募中2 期

Effectiveness of Vitamin C in reducing morbidity in patients with Dengue fever - A double blinded randomized placebo controlled pilot study.

Jonathan Orchard BSc(Hons) MBAcC0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Male and female patients aged 12-70 years.
  • 2. Previously healthy patients coming with dengue fever
  • 3. Within the first 3 days of fever
  • 4. Positive NS1 dengue antigen
  • 5. Platelet count more than 100 000/mm3

排除标准

  • 1. Patients under age of 12 years and above 70 years
  • 2. Those who have any evidence of plasma leakage, shock or impeding shock, fluid overload, internal bleeding at that time of recruitment
  • 3. Those who have severe vomiting or inability to take oral fluids
  • 4. Drowsy patients - Drowsiness will be assessed clinically based on appearance followed by glasgow coma scale.
  • 5. Those who have liver failure with clinical or biochemical evidence
  • 6. Those who have AST or ALT more than 100 IU/L on admission
  • 7. Patients with other co-morbidities such as diabetes mellitus, hypertension, ischemic heart disease, bronchial asthma, thyroid disorders etc.
  • 8. Patients who are on other medication (statins, metformin, beta blockers)
  • 9. Patients who are severely dehydrated
  • 10. Patients who get admitted later (more than 3 days after onset of fever)
  • 11. Patients who are extremely obese,- BMI more than 27 kg/m2
  • 12. Patients with known fatty liver disease
  • 13. Patients who have used any alternative medicine eg:- indigenous medicine
  • 14. Patients with diagnosed mental illness
  • 15. Patients with ongoing other infections, malignancy

研究者

发起方
Jonathan Orchard BSc(Hons) MBAcC

相似试验